NASDAQ:IDXG
Interpace Diagnostics Group Stock News
$1.48
+0.100 (+7.25%)
At Close: May 24, 2024
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
04:01pm, Thursday, 09'th May 2024
PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the first quarter ended March 31
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
08:00am, Thursday, 07'th Mar 2024
PARSIPPANY, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fourth quarter and full ye
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
03:29pm, Wednesday, 08'th Nov 2023
PARSIPPANY, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended Septemb
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
12:30pm, Wednesday, 09'th Aug 2023
PARSIPPANY, NJ, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the second quarter ended June 3
PARSIPPANY, NJ, July 10, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced preliminary business results for the second quarter e
Interpace Biosciences begins $30M rights offering
10:04pm, Wednesday, 12'th Jan 2022 Seeking Alpha
Interpace Biosciences (IDXG) began its previously announced fully back-stopped rights offering of up to $30M
Interpace Biosciences Announces New $7.5 Million Credit Facility with Comerica Bank
09:15am, Friday, 15'th Oct 2021
PARSIPPANY, NJ, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along with its subsidiaries, has entered int
Interpace Biosciences, Inc. (IDXG) Reports Q2 Loss, Tops Revenue Estimates
09:36pm, Tuesday, 10'th Aug 2021
Interpace Biosciences, Inc. (IDXG) delivered earnings and revenue surprises of -72.92% and 0.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the st
Interpace Biosciences, Inc. (IDXG) Is a Great Choice for "Trend" Investors, Here's Why
09:46am, Thursday, 01'st Jul 2021
Interpace Biosciences, Inc. (IDXG) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
04:47pm, Tuesday, 11'th May 2021
PARSIPPANY, NJ, May 11, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fiscal quarter ended March 3
Interpace Biosciences Raises Full Year 2021 Revenue Guidance
07:05am, Monday, 19'th Apr 2021
Parsippany, NJ, April 19, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced an update to its full year 2021 revenue guidance ori
Interpace Pharma Solutions Announces New Advanced Offering in RNA Biomarker Analysis
07:05am, Monday, 12'th Apr 2021
Parsippany, NJ, April 12, 2021 (GLOBE NEWSWIRE) -- Interpace Pharma Solutions, a subsidiary of Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today new capa
Interpace Biosciences Announces New PLA Code and Medicare Reimbursement Increase for Proprietary Thyroid Assay, ThyGeNEXT®
04:05pm, Monday, 05'th Apr 2021
Parsippany, NJ, April 05, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today that Novitas, its Medicare Administrative Contracto
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results
05:20pm, Wednesday, 31'st Mar 2021
PARSIPPANY, NJ, March 31, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fiscal quarter ended Decem
Interpace Biosciences Announces Divestiture of New Haven CLIA lab to DiamiR
07:30am, Wednesday, 17'th Mar 2021
Part of Company's Site Consolidation and Cost Savings Measures
